by George Ciuciureanu | Dec 3, 2025 | Health, News
Dec 3, 2025 – The Spondylitis Association of America (SAA) has published a new article and featured Augurex’s latest data from the American College of Rheumatology (ACR) 2025 conference in their eSUN newsletter. Read the full article on the SAA website: New Research...
by George Ciuciureanu | Nov 25, 2025 | Health, News
November 25, 2025 – Neil Klompas, CEO and President of Augurex, was featured on the Progress, Potential, and Possibilities Podcast, hosted by Dr. Ira Pastor. 🎧 Listen to the full episode: In the episode “Ending Diagnostic Delays in Autoimmune Conditions,” Neil...
by George Ciuciureanu | Nov 24, 2025 | Health, News
November 21, 2025 – Dr. Norma Biln, Augurex Co-founder and Chair of the Board, was featured on the Spondycast Podcast, hosted by the Spondylitis Association of America. 🎧 Listen to the full Spondycast episode: In Episode 121: Closing the Diagnosis Delay in...
by George Ciuciureanu | Nov 17, 2025 | Events, Health
Augurex expands its 14-3-3eta test availability through a new partnership with Sonic Reference Laboratory, a division of Sonic Healthcare USA, to enhance the diagnosis and management of rheumatoid arthritis. The 14-3-3eta test will launch at Sonic Reference Laboratory...
by George Ciuciureanu | Oct 31, 2025 | Health, News
Vancouver, Canada – October 31, 2025 – Augurex Life Sciences, a leader in autoimmune biomarker-based diagnostics, today announced that RheumNow, a leading rheumatology news platform, has featured Augurex’s latest ACR Convergence 2025 data on the Anti-14-3-3eta...
